Your browser doesn't support javascript.
loading
Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations.
Campbell, Joshua D; Lathan, Christopher; Sholl, Lynette; Ducar, Matthew; Vega, Mikenah; Sunkavalli, Ashwini; Lin, Ling; Hanna, Megan; Schubert, Laura; Thorner, Aaron; Faris, Nicholas; Williams, David R; Osarogiagbon, Raymond U; van Hummelen, Paul; Meyerson, Matthew; MacConaill, Laura.
Affiliation
  • Campbell JD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts2Cancer Program, Broad Institute of MIT and Harvard, Boston, Massachusetts.
  • Lathan C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Sholl L; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Ducar M; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Vega M; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Sunkavalli A; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Lin L; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Hanna M; Cancer Program, Broad Institute of MIT and Harvard, Boston, Massachusetts.
  • Schubert L; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Thorner A; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Faris N; Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.
  • Williams DR; Department of Social and Behavior Sciences, Harvard T. H. Chan School of Public Health, Boston, Massachusetts7Department of African and African American Studies, Harvard University, Cambridge, Massachusetts.
  • Osarogiagbon RU; Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.
  • van Hummelen P; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts2Cancer Program, Broad Institute of MIT and Harvard, Boston, Massachusetts4Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • MacConaill L; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts4Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
JAMA Oncol ; 3(6): 801-809, 2017 Jun 01.
Article in En | MEDLINE | ID: mdl-28114446

Full text: 1 Database: MEDLINE Main subject: Black or African American / Adenocarcinoma / Carcinoma, Non-Small-Cell Lung / White People / Lung Neoplasms / Mutation Type of study: Clinical_trials / Prevalence_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: JAMA Oncol Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Black or African American / Adenocarcinoma / Carcinoma, Non-Small-Cell Lung / White People / Lung Neoplasms / Mutation Type of study: Clinical_trials / Prevalence_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: JAMA Oncol Year: 2017 Type: Article